【Scientific Prowess】

She has taken charge of around ten projects entrusted by ministries and commissions, including three funded by National Natural Science Foundation, one funded by the Xinjiang Production and Construction Corps Doctor Fund, undertaken one sub-task of National Key Research and Development Program of China; edited eight books related to evidence-based medicine as chief editor or deputy chief editor; published more than 70 Chinese papers and over 30 SCI papers as the first/corresponding author. In 2013, she won the title of “Academic Star” of Asia-Pacific Pharmacoepidemiology Association. In 2018, she won the MECOR Young Scholar Award from the American Chest Association. In 2019, she was the coach for the “Special Prize” in the 27th Challenge Cup May 4th Youth Science Award of Peking University. She is also a backbone of the TCM inheritance and innovation team of the National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202010).

【Representative Programs】

[1] A key special sub-task of the 2021 National Key Research and Development Program “Study on Pathology and Epidemic Prevention Technology System”: December 2021 - November 2024, program title: “Study on Appropriate Methods for Active Monitoring of Vaccine Safety and Its Real-world Monitoring Strategy”.

[2] General program funded by National Natural Science Foundation (72074011): January 2021 - December 2024, program title: Estimation and Application of Actual Treatment Effects of Patients with Type 2 Diabetes: Study on Maximizing the Applicability of Clinical Trials.

[3] General program funded by National Natural Science Foundation (71673003): January 2017 - December 2020, program title: Construction and Application of the Evidence-based Evaluation Method System for Tumor Screening in China.

[4] A program funded by the Youth Fund of National Natural Science Foundation (81302508): January 2014 - December 2016, program title: Quality Evaluation of Multi-treatment Comparison Meta Analysis and Study on Several Key Statistical Methods.

[5] The Center for Drug Evaluation of National Medical Products Administration: August 2019 - August 2020, program title: Study on Statistical Analysis Methods of Active Monitoring Data.

[6] Chinese Drug Regulatory Science Action Plan of the National Medical Products Administration: June 2019 - May 2021, program title: Study on Safety Monitoring and Evaluation Methods of Post-marketing Drugs in the Drug Regulatory Science Research Program

[7] A special research program of clinical toxicology of Chinese Toxicology Society: December 2020 - March 2021, program title: Statistical Analysis Strategy for Study on Adverse Events of Live-kidney Injury Related with the Covid-19 Drugs.

[8] A special research program of clinical toxicology of Chinese Toxicology Society: November 2020 - November 2021, program title: Study on the Establishment of a Cohort of Heart Failure Risk Caused by Three New Types of Hypoglycemic Drugs Based on Multiple Sources and Dimensions and Their Causal Inference Strategy.

[9] A project entrusted by Beijing Health Promotion Association (88442Y0435): September 2020 - July 2021, program title: Systematic Review and Mesh Meta Analysis of Type 2 Diabetes Patients Treated with SGLT2 Inhibitor.

【Main Achievements】

Currently, she is serving as deputy director of Evidence-based Medicine Board, Chinese Medical Doctor Association, a member of the standing committee and deputy secretary general of the Clinical Toxicology Board of Chinese Toxicology Society, deputy director of the Health Big Data Special Committee of Beijing Research Association for Chronic Diseases Control and Health Education, deputy director of the Tumor Chemotherapy Special Committee of China Association for Promotion of Health Science and Technology, a member of the Clinical Epidemiology and Evidence-based Medicine Branch of Beijing Medical Association, a member of Beijing GRADE Center, a young member and deputy director of the Pharmacoepidemiology Special Committee of China Pharmaceutical Association, a member of the standing committee of Evidence-based Medicine Branch of China International Exchange and Promotive Association for Medical and Health Care, a member of the standing committee (and the academic secretary) of the evidence-based medicine textbooks compiling committee for colleges and universities of China. She also serves as a member of the editorial board or corresponding editorial board of journals such as Chinese Medicine Journal (English Version), Chinese Journal of Epidemiology, Chinese Journal of Evidence-Based Cardiovascular Medicine, Chinese Journal of Evidence Based Pediatrics and Chinese Journal of Pharmacoepidemiology.

【Research Orientations】Evidence-based medicine, Pharmacoepidemiology

【Enrollment Majors】Electronic information

【Contact Information】sunfeng@bjmu.edu.cn